Comparison late cutaneous complications between exposure to sulfur mustard and nerve agents

Cutaneous and Ocular Toxicology

Volumn 31, Issue 3, 2012, Pages 214-219

  Emadi, Seyed Naser ^a,b,c   Aslani, Jafar ^b   Poursaleh, Zohreh ^b   Izadi, Morteza ^d   Soroush, Mohammadreza ^b   Kafashi, Mohammad ^b   Alavinia, Seyed Ali ^b   Bakhshi, Hossein ^b   Karimi, Amir ^b   Momtaz Manesh, Kourosh ^b   Babaei, Ali Akbar ^b   Esmaili, Alireza ^b   Raygan, Babak ^b   Emadi, Seyed Emad ^b   Babamahmoodi, Farhang ^a   Emadi, Seyed Abolfazl ^e  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Baghiyatallah University   (Iran)

^e JANBAZAN MEDICAL AND ENGINEERING RESEARCH CENTER JMERC   (Iran)

Author keywords

Cutaneous; Nerve agents; Sulfur mustard

Indexed keywords

CHEMICAL WARFARE AGENT; MUSTARD GAS; NERVE AGENT; UNCLASSIFIED DRUG;

ACNE; ADULT; ALOPECIA AREATA; AMYLOIDOSIS; ANGIOMA; ARTICLE; BLISTER; DEPIGMENTATION; DERMATOLOGIST; ECZEMA; FEMALE; FOLLICULITIS; HUMAN; HYPERPIGMENTATION; INTERTRIGO; KERATOSIS; LENTIGO; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEURODERMATITIS; POIKILODERMA; SCAR; SEBORRHEIC DERMATITIS; SKIN TOXICITY; SKIN TUMOR; TINEA VERSICOLOR; XEROSIS;

ADULT; CHEMICAL WARFARE AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSTARD GAS; SKIN;

EID: 84865327500     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.641196     Document Type: Article

References (39)

1. Szinicz L. History of chemical and biological warfare agents. Toxicology 2005;214:167-181. (Pubitemid 41406257)
2. Somani SM. (1992) Chemical warfare agents. New York, USA: Academic Press Company Inc.
3. Balali-Mood M, Shariat M. Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the efects of oximes. J Physiol Paris 1998;92:375-378. (Pubitemid 29046492)
4. United Nations Security CouncilReport of the mission dispatched by the Secretary General to investigate allegations of the use of chemical weapons in the confict between the Islamic Republic of Iran and Iraq. Jun.30, 1987. S/18956. New York, USA, United Nations Security Council, 1987.
5. United Nations Security Council. Report of Specialists Appointed by the Secretary General to Investigate Allegations by the Islamic Republic of Iran Concerning the Use of Chemical Weapons. United Nations SecurityCouncil Publication S/16433/1986. New York, NY: United Nations Security Council, 1986.
6. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34, 000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003;45:1136-1143. (Pubitemid 37420858)
7. Kai K, Ladislaus S. Medical aspects of sulphur mustard poisoning. Toxicology 2005;214:198-209.
8. Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED et al. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig. Hum Exp Toxicol 2005;24:347-352. (Pubitemid 41139580)
9. Renshaw B. Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. Chemical warfare agents and related chemical problems 1945;9:478-520.
10. Krieger RI. (2001). Handbook of pesticide toxicology. San Diego, CA, USA: Academic Press.
11. Holstege CP, Kirk M, Sidell FR. Chemical warfare. Nerve agent poisoning. Crit Care Clin 1997;13:923-942. (Pubitemid 27432898)
12. Benford DJ, Cocker J, Sartorelli P, Schneider T, van Hemmen J, Firth JG. Dermal route in systemic exposure. Scand J Work Environ Health 1999;25:511-520. (Pubitemid 30015687)
13. Emadi SN, Mortazavi M, Mortazavi H. Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: A longterm investigation. Arch Dermatol 2008;144:1059-1061.
14. OPCW. (2002). Suggestions for interviewing chemical weapons witnesses. In: 4th course on medical aspects of defense against chemical weapons.Tehran, Iran.
15. Constance M, Pechura DPR. (1993). Veterans at risk: health efects of mustard gas and lewisite. Washington, DC, USA: National Academic Press.
16. Emadi SN, Hosseini-Khalili A, Soroush MR, Davoodi SM, Aghamiri SS. Mustard gas scarring with specifc pigmentary, trophic and vascular charactristics (case report, 16-year post-exposure). Ecotoxicol Environ Saf 2008;69:574-576. (Pubitemid 351305014)
17. Heidari MR, Karami nejad M, Ansari H. Prevalence of delayed skin efects of mustard gas. Danesh J 1999;7:67-73.
18. Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992;128:775-780.
19. Balali-Mood M, Hefazi M, Mahmoudi M, et al. Long-term complications of sulfur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 2005;19:713-21. (Pubitemid 43822007)
20. Rashidi T, Ghavam F, Alamdari A, et al. Evaluation of pathological and clinical characteristic of late skin lesions following mustard gas exposure. Uro Med J 1998;8:1-10.
21. Fekri AR, Janghorbani M. Late skin complications in mustard gas victims of Iran-Iraq war in Kerman province. J Ker Univ Med Sci 1994;2:108-119.
22. Chauhan RS, Murthy LV, Arora U, Malhotra PR. Structural changes induced by sulphur mustard in rabbit skin. J Appl Toxicol 1996;16:491-495. (Pubitemid 26402942)
23. Smith KJ. Te prevention and treatment of cutaneous injury secondary to chemical warfare agents. Application of these fnding to other dermatologic conditions and wound healing. Dermatol Clin 1999;17:41-60. (Pubitemid 29062076)
24. Smith KJ, Skelton H. Chemical warfare agents: Teir past and continuing threat and evolving therapies. Part I of II. Skinmed 2003;2:215-221.
25. Willems JL. Clinical management of mustard gas casualties. Ann Med Mil 1989;3:1-60.
26. Papirmeister B, Feister AJ, Robinson SI, Ford RD. (1991). Chemistry of sulfur mustard. Medical Defense against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. Boston: CRC. pp 91-122.
27. Balali-Mood M, Balali-Mood K. Neurotoxic disorders of organophosphorus compounds and their managements. Arch Iran Med 2008;11:65-89. (Pubitemid 351233553)
28. Sivam S, Hoskins B, et al. An assessment of comparative acute toxicity of diisopropyl-fuorophosphate, Tabun, Sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats. Fundam Appl Toxicol 1984;19:23-32.
29. Worek F, Kleine A, Falke K, Szinicz L. Arrhythmias in organophosphate poisoning: Efect of atropine and bispyridinium oximes. Arch Int Pharmacodyn Ter 1995;329:418-435.
30. De Bleecker J, Van den Neucker K, Willems J. Te intermediate syndrome in organophosphate poisoning: Presentation of a case and review of the literature. J Toxicol Clin Toxicol 1992;30: 321-331.
31. Hughes RA. Peripheral neuropathy. BMJ 2002;324:466-469. (Pubitemid 34169466)
32. Sneddon J, Sneddon I. Acne excoriée: A protective device. Clin Exp Dermatol 1983;8:65-68.
33. Ginsburg IH. Te psychosocial impact of skin disease. An overview. Dermatol Clin 1996;14:473-484. (Pubitemid 26249397)
34. Kligman AM. An overview of acne. J Invest Dermatol 1974;62:268-287.
35. Ginsburg IH. Te psychosocial impact of skin disease. Dermatol Clin 1996;14:473-484.
36. Freid RG. Evaluation and treatment of psychogenic pruritus and selfexcoriation. JAm Acad Dermatol 1994;30:993-999.
37. Foroutan Abbas. (2003). Medical experiences of iraq's chemical warfare. Tehran, Iran: Baqiyatallah University of Medical Sciences.
38. Ghanei M, Harandi AA. Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: A review. Inhal Toxicol 2011;23:363-371.
39. Newmark J. Te birth of nerve agent warfare: Lessons from Syed Abbas Foroutan. Neurology 2004;62:1590-1596. (Pubitemid 38608201)